Clinical Trial Update: Raltitrexed in Treating Children With Refractory Acute Leukemia [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 clinical trial of Raltitrexed for refractory acute leukemia in children, including recurrent childhood acute lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Tomudex (ZD1694)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED